tiprankstipranks
Edgewise Therapeutics, Inc. (EWTX)
NASDAQ:EWTX
US Market
EWTX
Edgewise Therapeutics
RESEARCH TOOLSreports
Want to see EWTX full AI Analyst Report?

Edgewise Therapeutics (EWTX) Income Statement

420 Followers

Edgewise Therapeutics Income Statement

Last quarter (Q1 2026), Edgewise Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Edgewise Therapeutics's net income was $-49.01M. See Edgewise Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -2.27M$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 189.14M$ 158.83M$ 114.36M$ 71.66M$ 43.22M
Depreciation and Amortization
$ 2.27M$ 2.29M$ 1.73M$ 538.00K$ 272.00K
EBITDA
$ -165.53M$ -156.54M$ -112.63M$ -71.12M$ -42.94M
Operating Income
$ -191.41M$ -158.83M$ -114.36M$ -71.66M$ -43.22M
Other Income/Expenses
$ 23.61M$ 25.02M$ 14.19M$ 4.02M$ 402.00K
Pretax Income
$ -167.79M$ -133.81M$ -100.16M$ -67.64M$ -42.81M
Net Income
$ -167.79M$ -133.81M$ -100.16M$ -67.64M$ -42.81M
Per Share Metrics
Basic EPS
$ -1.63$ -1.45$ -1.57$ -1.26$ -0.86
Diluted EPS
$ -1.63$ -1.45$ -1.57$ -1.26$ -0.86
Weighted Average Shares Outstanding
 102.93M 92.41M 63.72M 53.59M 49.50M
Weighted Average Shares Outstanding (Diluted)
 102.93M 92.41M 63.72M 53.59M 49.50M
Currency in USD

Edgewise Therapeutics Earnings and Revenue History